Terms: = Breast cancer AND LDH AND Clinical Outcome
4 results:
1. Warburg Effect Metabolism Drives Neoplasia in a Drosophila Genetic Model of Epithelial cancer.
Eichenlaub T; Villadsen R; Freitas FCP; Andrejeva D; Aldana BI; Nguyen HT; Petersen OW; Gorodkin J; Herranz H; Cohen SM
Curr Biol; 2018 Oct; 28(20):3220-3228.e6. PubMed ID: 30293715
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia.
Zhang Y; Zhou X; Li Y; Xu Y; Lu K; Li P; Wang X
Oncogene; 2018 Oct; 37(41):5520-5533. PubMed ID: 29895969
[TBL] [Abstract] [Full Text] [Related]
3. Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
Doyen J; Trastour C; Ettore F; Peyrottes I; Toussant N; Gal J; Ilc K; Roux D; Parks SK; Ferrero JM; Pouysségur J
Biochem Biophys Res Commun; 2014 Aug; 451(1):54-61. PubMed ID: 25058459
[TBL] [Abstract] [Full Text] [Related]
4. The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts.
Bonuccelli G; Whitaker-Menezes D; Castello-Cros R; Pavlides S; Pestell RG; Fatatis A; Witkiewicz AK; Vander Heiden MG; Migneco G; Chiavarina B; Frank PG; Capozza F; Flomenberg N; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Cell Cycle; 2010 May; 9(10):1960-71. PubMed ID: 20495363
[TBL] [Abstract] [Full Text] [Related]
